Capital Flow Monitor · Sponsors · CIK 1798436
EpiBone, Inc.
521 5TH AVE, 17TH FLOOR, NEW YORK, NY, 10175 · 212-653-8828
Other · Corporation· inc. DELAWARE true
Fit score
—
Offering
$4.3M
Sold
$4.3M
% sold
99.7%
Investors
131
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-24 | D ·current | 506(b) | $4.3M | $4.3M | 99.7% | 131 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Nina Tandon — Executive Officer / Director, New York, NY
- Sarindr Bhumiratana — Executive Officer / Director, New York, NY
- Gordana Vunjak-Novakovic — Director, New York, NY
-
Robert Langer — Director, New York, NY
3 other raises
- Noveome Biotherapeutics, Inc. $6.8M of $15.0M · 45.0%
- VitaKey Inc. $0 of $43.5M · 0.0%
- SYNTIS BIO, INC. $25.0M of $26.5M · 94.3%
-
David Zhu — Director, New York, NY
2 other raises
- Rejuvenate Bio Inc $19.5M of $27.0M · 72.0%
- QUANTUM FUND S LP $0 of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.